Purpose: To determine the relationship between photon sensitivity and neutron sensitivity and between neutron RBE and photon resistance for two neutron modalities (with mean energies of 6 and 29 MeV) using human tumor cell lines spanning a wide range of radiosensitivities, the principal objective being whether or not a neutron advantage can be demonstrated. Methods and Materials: Eleven human tumor cell lines with mean photon inactivation doses of 1.65–4.35 Gy were irradiated with 0–5.0 Gy of p(66)/Be neutrons (mean energy of 29 MeV) at Faure, S.A. and the same plating was irradiated on the same day with 0–10.0 Gy of Cobalt-γ-rays . Twelve human tumor cell lines, many of which were identical with the above selection, and spanning mean photon inactivation doses of 1.75–4.08 Gy, were irradiated with 0–4 Gy of d(14)/Be neutrons (mean energy of 6 MeV) and with 0–10 Gy of 240 kVp X-rays at the Essen Klinikum. Cell survival was determined by the clonogenic assay, and data were fitted to the linear quadratic equation. Results: 1. Using the mean inactivation dose, a significant correlation was found to exist between neutron sensitivity and photon sensitivity. However, this correlation was more pronounced in the Faure beam ( r 2 = 0.89 , p ≤ 0.0001) than in the Essen beam (r 2 = 0.65, p = 0.0027). 2. No significant relationship could be established between neutron RBE and photon resistance for both modalities ( p = 0.69 and p = 0.07, respectively). 3. Using α-coefficients as a criterion, the neutron sensitivity for the Faure beam correlated with photon sensitivity ( p = 0.001), but this did not apply to the Essen beam ( p = 0.27). 4. The neutron RBE for the Essen beam derived from α-coefficients showed a steep increase with photon resistance ( p = 0.003). In the Faure beam there was no increase of RBE with photon resistance ( p = 0.494). Conclusion: Radiobiological differences between high-energy and low-energy neutrons are particularly apparent in the dependence of the neutron RBE on photon sensitivity. The increase of RBE with photon resistance is more pronounced in the low-energy Essen neutrons than in the high-energy Faure neutrons. An RBE advantage is indicated for photon-resistant cell lines and this is particularly apparent in the low-dose range using α-coefficients as compared to the mean inactivation dose. The clinical application of low-energy neutrons may be more restricted because of poor penetration and lack of skin sparing. However, these neutrons discriminate better between photon-sensitive and photon-resistant cells giving an RBE range of 2–6 and a mean RBE of 4.1, than high-energy neutrons where the RBE range is 1.6–3.5 and the mean RBE is 2.4. From the radiobiological point of view it, therefore, appears that the clinical potential of low-energy neutrons is considerably underrated.